Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).

Barouch, DH; Tomaka, FL; Wegmann, F; Stieh, DJ; Alter, G; Robb, ML; Michael, NL; Peter, L; Nkolola, JP; Borducchi, EN; +46 more... Chandrashekar, A; Jetton, D; Stephenson, KE; Li, W; Korber, B; Tomaras, GD; Montefiori, DC; Gray, G; Frahm, N; McElrath, MJ; Baden, L; Johnson, J; Hutter, J; Swann, E; Karita, E; Kibuuka, H; Mpendo, J; Garrett, N; Mngadi, K; Chinyenze, K; Priddy, F; Lazarus, E; Laher, F; Nitayapan, S; Pitisuttithum, P; Bart, S; Campbell, T; Feldman, R; Lucksinger, G; Borremans, C; Callewaert, K; Roten, R; Sadoff, J; Scheppler, L; Weijtens, M; Feddes-de Boer, K; van Manen, D; Vreugdenhil, J; Zahn, R; Lavreys, L; Nijs, S; Tolboom, J; Hendriks, J; Euler, Z; Pau, MG; Schuitemaker, H; (2018) Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19). Lancet, 392 (10143). pp. 232-243. ISSN 0140-6736 DOI: https://doi.org/10.1016/S0140-6736(18)31364-3

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S0140-6736(18)31364-3

Abstract

Item Type Article
PubMed ID 30047376
Related URLs

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar